Cefuroxime 10mg/mL INJ 0 — Class II drug recall D-1076-2019
Terminated recall by Pacific Compounding Pharmacy & Consultations Inc, reported 2019-04-10, distributed in CA. Presence of Particulate Matter: Particulate matter was reported in one lot of Cefuroxime by a physician after
| Recall number | D-1076-2019 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Pacific Compounding Pharmacy & Consultations Inc, Stockton, CA, United States |
| Recall initiated | 2018-08-23 |
| Classified | 2019-04-02 |
| Reported by FDA | 2019-04-10 |
| Terminated | 2023-04-27 |
| Distributed | CA |
| Quantity | 41.4 ml |
| Reason classes | specification failure |
| Expiration dates | 2018-09-06 |
Product
Cefuroxime 10mg/mL INJ 0.5 mg, SDV, Rx only, Pacific Compounding, Stockton, CA
Reason for recall
Presence of Particulate Matter: Particulate matter was reported in one lot of Cefuroxime by a physician after use of product.. FDA analysis identified the particulate as coring of the rubber stopper
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1076-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.